Skip to main navigation

Overview
New & Events
- Press Releases
- Events & Presentations
Stock Information
Financial Information
- Quarterly Results
- SEC Filings
Corporate Governance
Investor Resources

Press Releases

Press Releases

Year

Jul 16, 2020

Pandion Therapeutics Announces Pricing of Initial Public Offering

Jun 09, 2020

Pandion Therapeutics Announces Issuance of U.S. Patent for Bifunctional Molecules Derived from TALON™ Platform

May 19, 2020

Pandion Therapeutics Appoints John S. Sundy, M.D., Ph.D. as Chief Medical Officer

Apr 01, 2020

Pandion Therapeutics Announces Close of $80 Million Series B Financing

Feb 25, 2020

Pandion Therapeutics to Present at Cowen & Co. 40th Annual Health Care Conference

Feb 24, 2020

Pandion Announces First Subject Dosed in a Phase 1 Clinical Trial of PT101, an IL-2 Mutein Fc Fusion Therapy for Autoimmune Disease

Feb 18, 2020

Pandion Therapeutics to Present at SVB Leerink 9th Annual Global Healthcare Conference

Jan 28, 2020

Pandion Therapeutics Announces Appointment of Don Frail, PhD, to Its Board of Directors

Print Page

RSS Feeds

Email Alerts

Investor Contact

Investor Contact

© 2020 Pandion Therapeutics. All rights reserved.